These compounds disrupt the Keap1-Nrf2 interaction and promote Nrf2 translocation, thereby enhancing antioxidant and anti-inflammatory effects to counteract the progression of multiple sclerosis. The gene discussed is NFE2L2; the disease is multiple sclerosis.